Creatine for Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2014-06-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD009646.pub2PMID 24934384PMCID PMC10196714
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Published by John Wiley & Sons Ltd

  2015cited by this paper
• Design innovations and baseline findings in a long‐term Parkinson's trial: The national institute of neurological disorders and stroke exploratory trials in Parkinson's Disease Long‐Term Study–1

  2012cited by this paper
• Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience.

  2009cited by this paper
• Parkinson's disease (vol 373, pg 2055, 2009)

  2009cited by this paper
• A Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson Disease: 18-Month Results

  2008cited by this paper
• Long-term creatine supplementation is safe in aged patients with Parkinson disease.

  2008cited by this paper
• Epidemiology of Parkinson’s disease

  2008cited by this paper
• Resistance Training With Creatine Monohydrate Improves Upper-Body Strength in Patients With Parkinson Disease: A Randomized Trial

  2007cited by this paper
• Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030

  2007cited by this paper
• Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson’s disease

  2007cited by this paper
• A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease.

  2006cited by this paper
• A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease

  2006cited by this paper
• Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity.

  2006cited by this paper
• Optimizing the ongoing search for new treatments for Parkinson disease

  2006cited by this paper
• Creatine supplementation in Parkinson disease: A placebo-controlled randomized pilot trial

  2006cited by this paper
• Epidemiology of Parkinson's disease.

  2006cited by this paper
• The therapeutic role of creatine in Huntington's disease.

  2005cited by this paper
• Mitochondria take center stage in aging and neurodegeneration

  2005cited by this paper
• Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials.

  2004cited by this paper
• Neuroprotective agents for clinical trials in Parkinson’s disease: A systematic assessment

  2004cited by this paper
• Biomedicine. Parkinson's--divergent causes, convergent mechanisms.

  2004cited by this paper
• Parkinson's--Divergent Causes, Convergent Mechanisms

  2004cited by this paper
• Parkinson's disease

  2004cited by this paper
• Neuroprotective agents for clinical trials in Parkinson’s disease

  2003cited by this paper
• Direct antioxidant properties of creatine.

  2002cited by this paper
• Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders

  2001cited by this paper
• Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature

  2001cited by this paper
• Cellular and Molecular Mechanisms Underlying Perturbed Energy Metabolism and Neuronal Degeneration in Alzheimer's and Parkinson's Diseases

  1999cited by this paper
• Creatine and cyclocreatine attenuate MPTP neurotoxicity.

  1999cited by this paper
• Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

  1995cited by this paper
• Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.

  1973cited by this paper

• Impacts of Muscle Enzyme Levels on Progression and Survival in ALS Population: A Cohort Study and Meta‐Analysis

  2026cites this paper
• Creatine-weighted imaging in patients with Parkinson’s disease

  2025cites this paper
• Creatine-weighted imaging in patients with Parkinson disease

  2025cites this paper
• Gut Microbiota Approach—A New Strategy to Treat Parkinson’s Disease

  2020cites this paper
• Creatine as a Neuroprotector: an Actor that Can Play Many Parts

  2019cites this paper
• Emergent Prophylactic, Reparative and Restorative Brain Interventions for Infants Born Preterm With Cerebral Palsy

  2019cites this paper
• Impairment of Motor Function Correlates with Neurometabolite and Brain Iron Alterations in Parkinson’s Disease

  2019cites this paper
• Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders

  2019cites this paper
• Acceptability of dietary or nutritional supplementation in pregnancy (ADONS) - Exploring the consumer's perspective on introducing creatine monohydrate as a pregnancy supplement.

  2019cites this paper
• The effectiveness of creatine treatment for Parkinson’s disease: an updated meta-analysis of randomized controlled trials

  2017influential citation
• Creatine and creatine forms intended for sports nutrition

  2017cites this paper
• Nutritional habits, risk, and progression of Parkinson disease

  2017cites this paper
• Neuronutrition: An Emerging Concept

  2017cites this paper
• Creatine for neuroprotection in neurodegenerative disease: end of story?

  2016cites this paper
• Why We Cannot Translate Successful Results to New Therapies in Parkinson’s Disease

  2016cites this paper
• Creatine for women in pregnancy for neuroprotection of the fetus.

  2014cites this paper
• Identificação de biomarcadores em fluidos biológicos para o diagnóstico precoce da Doença de Parkinson: Realidade ou Utopia?

  2014cites this paper
• Effects of Amide Creatine Derivatives in Brain Hippocampal Slices, and Their Possible Usefulness for Curing Creatine Transporter Deficiency

  2013cites this paper